The Vertex scientists helped change that by creating a new class of drugs that reduce mortality by 74 percent. Trikafta can increase the life expectancy of people with the disease to about 83 ...

The Food and Drug Administration announced on Monday (October 21)—months ahead of its expected decision date—that it has approved a new treatment for cystic fibrosis. Trikafta, made by Vertex ...

You've probably heard a lot about something called the Pharmaceutical Benefits Scheme — or the PBS — this week. Here are some ...

Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and ...

My evolving relationship with cystic fibrosis brings feelings of guilt and jealousy but also a deep sense of gratitude and understanding.

Corporations that develop and market lifesaving drugs are somewhat insulated from ... with one of Vertex's most effective medicines, Trikafta. That number stands at 33% in other countries.